Electroconvulsive Therapy: Clinical Trials

6 trials of Electroconvulsive Therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 suspended, 1 withdrawn. 6 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Completed 4, Suspended 1, Withdrawn 1
Phase 23Completed 3

Follow Electroconvulsive Therapy: new trials by email Literature Review of Electroconvulsive Therapy trials Research Report on Electroconvulsive Therapy

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ECT vs. Esketamine
Esketamine nasal spray, Electroconvulsive therapy - Treatment Resistant Depression, Major Depressive Disorder
Phase 3WithdrawnMedical University Innsbruck2021-07-282022-08-05
Electro-Magnetic Convulsive Therapies for Depression: a Non-inferiority Study
Magnetic Seizure Therapy, Electroconvulsive Therapy - Major Depressive Disorder, Bipolar Depression
Phase 2 / Phase 3CompletedUniversity of Sao Paulo1002021-05-312026-09-29
Ketamine Versus Electroconvulsive Therapy in Depression
Intravenous Ketamine, Electroconvulsive Therapy - Depressive Disorder, Major, Bipolar Depression
Phase 3SuspendedUniversity of Ottawa2402018-10-292023-09-01
ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)
electroconvulsive therapy (ECT), Ketamine - Treatment Resistant Depression, Electroconvulsive Therapy
Phase 2 / Phase 3CompletedBo Hu4032017-04-072023-09-28
Understanding How Anaesthesia Affects ECT Outcomes
Electroconvulsive Therapy (ECT) time interval + Anaesthetic (Thiopentone) - Depression
Phase 3CompletedThe University of New South Wales542017-03-152023-03-30
The Antidepressant Effect of Repetitive Transcranial Magnetic Stimulation (rTMS)Compared to ECT
Right prefrontal lowfrequency ( 1 hz) rTMS., Electroconvulsive therapy (ECT) - Depressive Disorder
Phase 2 / Phase 3CompletedUniversity of Aarhus602002-05-012008-07-02

Conditions studied

Depression (4)  ·  Depressive Disorder, Major (4)  ·  Bipolar Disorder (2)  ·  Depressive Disorder (2)  ·  Depressive Disorder, Treatment-Resistant (2)  ·  Mental Disorders (1)

Sponsors

Bo Hu (1)  ·  Medical University Innsbruck (1)  ·  The University of New South Wales (1)  ·  University of Aarhus (1)  ·  University of Ottawa (1)  ·  University of Sao Paulo (1)

Countries

Australia (1)  ·  Austria (1)  ·  Brazil (1)  ·  Canada (1)  ·  Denmark (1)  ·  United States (1)

Top investigators

Amit Anand, MD (1)  ·  Colleen Loo, MBBS (1)  ·  Pierre Blier, MD, PhD (1)  ·  Poul Erik Buchholtz Hansen, senior phys. (1)

Results publications

PMID 20351570, PMID 30572160, PMID 32487236, PMID 35900079, PMID 37224232, PMID 40900112